From etiology and pathogenesis to therapy of multiple sclerosis.
The Author describes the histopathologic picture of the Multiple Sclerosis and Experimental Allergic Encephalitis and discusses some etiopathogenetic hypotheses elaborating on the immunogenetic and immunopathological aspects. The therapeutical problem is analyzed in all its various facets: cortisone derivatives, immunosuppressive products and reabilitation therapy aiming simultaneously at motion reeducation and at individual and group psycotherapy.
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D009103:Multiple Sclerosis / Q000628:therapy; D011725:Pyridines / Q000627:therapeutic use; D011817:Rabbits
D007166:Immunosuppressive Agents; D011725:Pyridines; D003907:Dexamethasone; D001379:Azathioprine; D003348:Cortisone